Green Stone Swiss Co ., ltd.

PPARα LBD (human recombinant)

Stability : 6 months
Formulation :
A solution in 50 mM sodium phosphate, pH 7.2, containing 20% glycerol, 100 mM sodium chloride, and 1 mM DTT
Description :
PPARα is highly expressed in tissues displaying a high catabolic rate of fatty acids such as the liver, skeletal muscles, brown fat, heart, kidneys, and cells of artherosclerotic lesions.  Fatty acids, NSAIDs, prostaglandins, leukotriene B4, WY 14643, and hypolipidemic drugs are PPARα ligands. PPARα transcriptionally regulates a variety of genes involved in fatty acid metabolism and oxidation, such as acyl-CoA oxidase, enol-CoA hydratase, medium chain fatty acyl-CoA dehydrogenase, fatty acid transport protein, and cytochrome P450 4A isozymes.
Purity : >90%
Storage : -80°C

Send enquiry online

s4After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@raw-pharmaceutical-materials.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6515 7632
4. Send enquiry online:

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.